December 31, 2021 were organizational activities, those necessary to prepare for the Initial Public Offering (“Initial Public Offering”) and identifying a target company for a business combination. The Company did not generate any operating revenues before the completion of the Business Combination. The Company did generate non-operating income in the form of investment income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. As of December 31, 2022 the Company incurred expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the year ended December 31, 2022, we had net income of $2,732,973, which resulted from a gain on fair value of warrant liability of $3,612,764, dividend income on investments held in the Trust Account in the amount of $1,702,524, and a gain on fair value of the Sponsor Working Capital Loan of $17,400, partially offset by formation and operating costs of $2,102,272, franchise tax expense of $200,000, income tax expense of $289,122, and interest expense of $8,321.
For the period from February 12, 2021 (inception) through December 31, 2021, we had net income of $4,585,547 which consisted of a gain on change in fair value of warrant liabilities of $5,621,902, bank incentive of $5 and interest income on marketable securities held in our Trust Account of $3,213 offset by formation and operational costs of $413,230, franchise tax expenses of $120,647 and transaction costs allocated to warrant liabilities of $505,696.
Going Concern, Liquidity and Capital Resources
For the year ended December 31, 2022, net cash used in operating activities was $1,233,766, which was due to the change in fair value of the warrant liability of $3,612,764 and interest and dividend income on the investments held in the Trust Account of $1,702,524, and change in fair value of the Sponsor Working Capital Loan of $17,400, partially offset by net income of $2,732,973, changes in working capital of $1,357,628, and interest expense of $8,321.
For the period from February 12, 2021 (inception) through December 31, 2021, net cash used in operating activities was $459,012, which was due to the change in fair value of warrant liability of $5,621,902, and interest earned on marketable securities held in the Trust Account of $3,213, partially offset by net income of $4,585,547, offering costs allocated to warrants of $505,696, changes in working capital of $74,631, and formation costs paid by a stockholder in the form of a capital contribution of $229.
For the year ended December 31, 2022, net cash used in investing activities was $2,170,000, which was due to investment of cash into the Trust Account of $2,300,000, partially offset by proceeds from the Trust Account used to pay taxes of $130,000.
For the period from February 12, 2021 (inception) through December 31, 2021, net cash used in investing activities was $116,725,000 due to investment of cash into the Trust Account.
For the year ended December 31, 2022, net cash provided by financing activities was 3,260,000 due to $960,000 received from the issuance of a Sponsor Working Capital Loan and $2,300,000 in proceeds from the sale of private placement units.
For the period from February 12, 2021 (inception) through December 31, 2021, net cash provided by financing activities was $117,521,607 due to proceeds received from the issuance of Class B common stock to the Sponsor of $25,000, proceeds from sale of Units, net of underwriting discount paid of $113,050,000, proceeds from sale of private placement units of $5,216,750, partially offset by payment of offering costs of $770,143.
The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company had $193,829 and $337,595 in cash and no cash equivalents as of December 31, 2022 and December 31, 2021, respectively.
110